Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

NASDAQ:ASRT

Assertio Holdings, Inc. Common Stock

Last Close

1.01

03/05 20:00

Market Cap

97.98M

Beta: 1.40

Volume Today

576.93K

Avg: 2.27M

PE Ratio

−0.35

PFCF: 1.07

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics